Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating allogeneic stem cell transplantation with alpha/beta T and B cell depletion for hematologic malignancies; …
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA [Phase 1, Phase 2]
This Phase 1/Phase 2 clinical trial is evaluating the combination of canakinumab and darbepoetin alfa in patients with lower-risk myelodyspl…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion [NA]
Clinical trial update from Baylor College of Medicine reports results for haploidentical hematopoietic cell transplantation using TCR alpha/…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia [Phase 2]
Phase 2 clinical trial update for UM171 expanding cord blood in patients with high-risk acute leukemia or myelodysplastic syndromes. The stu…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Resiliency in Older Adults Undergoing Bone Marrow Transplant
A completed clinical trial update from Johns Hopkins on resiliency in older adults undergoing bone marrow transplant for hematologic cancers…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
This ClinicalTrials.gov update describes an ongoing study that collects tissue, blood, and body fluid samples from patients with hematologic…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2, open-label pilot study of luspatercept for lower-risk myelodysplastic syndromes is currently recruiting at MD Anderson Cancer Cente…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a CD8-depleted, non-engrafting, HLA-mismatched unrelated donor infusion in patients with myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 study of etavopivat for anemia in patients with very low to intermediate risk myelodysplastic syndromes was terminated; results have…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update reports the termination of a Phase 1/2 study of INCB000928 in myelodysplastic syndromes and multiple myeloma, wit…
-
CLINICAL_TRIALS trial_result · 2025-10-22Clinical Trial Update: Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML [Phase 1]
Phase 1 clinical trial update evaluating eganelisib as a monotherapy and in combination with cytarabine in relapsed/refractory acute myeloid…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India [Phase 4]
Phase 4 clinical trial evaluating the safety and effectiveness of luspatercept for transfusion-dependent anemia associated with myelodysplas…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: IS-free Treg HaploHCT [Phase 1]
A Phase 1 clinical trial at Dana-Farber Cancer Institute evaluating an IS-free regulatory T cell haploidentical hematopoietic cell transplan…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS [NA]
Clinical trial investigating whole genome sequencing (ChromoSeq) as an adjunct to conventional genomic profiling in acute myeloid leukemia a…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating interferon-γ in combination with donor leukocyte infusion for relapsed acute myeloid leukemia and myelodys…
-
CLINICAL_TRIALS other · 2025-10-14Clinical Trial Update: Study to Evaluate the Safety and Tolerability of EP0042 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and tolerability of EP0042 from Ellipses Pharma is currently recruiting for acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS [Phase 1]
A Phase Ib study evaluating select drug combinations in lower-risk myelodysplastic syndromes has been terminated.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Umbilical Cord Blood Transplantation From Unrelated Donors
This is an ongoing clinical trial evaluating umbilical cord blood transplantation from unrelated donors for hematologic diseases. The study …
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-0610 with and without ruxolitinib in patients with hematologic and myeloproliferative malignancies. …
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial from University of Alabama at Birmingham evaluating a two-step anti-thymocyte globulin regimen to prevent acute gra…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating a two-step anti-thymocyte globulin (ATG) regimen to prevent acute graft-versus-host disease after myeloablative all…
-
EMA approval · 2025-10-08EMA Authorised: Azacitidine Accord (azacitidine) — Accord Healthcare S.L.U.
EMA authorised Azacitidine Accord, a generic azacitidine product, for myelodysplastic syndromes and certain leukemias (acute myeloid leukemi…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients With Myelodysplastic Syndromes
A ClinicalTrials.gov entry outlining a study to assess the prognostic value of HALP score, monocytopenia, hypofibrinogenemia, and AST/ALT ra…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes
This clinical trial update concerns a Brescia-based study using next-generation sequencing to investigate familial acute myeloid leukemia an…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: A Study to Evaluate the MNV-201 in Patients With Low Risk MDS [Phase 1]
A Phase 1 clinical trial evaluating MNV-201 in patients with low-risk myelodysplastic syndromes, currently recruiting.